Advertisement
U.S. Markets closed

Hologic, Inc. (HOLX)

NasdaqGS - NasdaqGS Real Time Price. Currency in USD
Visitors trend2W10W9M
80.83-0.08 (-0.10%)
At close: 04:00PM EDT
80.83 0.00 (0.00%)
After hours: 05:16PM EDT
Full screen
Trade prices are not sourced from all markets
Previous Close80.91
Open80.89
Bid0.00 x 0
Ask0.00 x 0
Day's Range79.43 - 81.17
52 Week Range64.02 - 84.67
Volume1,264,268
Avg. Volume1,499,800
Market Cap18.895B
Beta (5Y Monthly)0.98
PE Ratio (TTM)27.59
EPS (TTM)2.93
Earnings DateNov 04, 2024
Forward Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target Est88.51
  • Benzinga

    Hologic Recalls Soft Tissue Marker Device BioZorb, FDA Issues Warning After Almost 400 Complaints

    On Friday, the FDA warned against using Hologic Inc.’s (NASDAQ:HOLX) BioZorb Marker products and urged healthcare facilities to return all unused lots. This follows Hologic’s voluntary recall of the BioZorb Marker and BioZorb LP Marker, implantable devices intended for marking sites in soft tissues like breast tissue. Also Read: Hologic Adds Gynesonics’ Sonata System In $350M Acquisition To Boost Fibroid Treatments The recall comes in response to reports of serious adverse events in patients, in

  • Zacks

    Will Non-COVID-19 Diagnostics Sales Drive Hologic's Q4 Earnings?

    HOLX's fiscal 2024 fourth-quarter results are expected to reflect a solid performance of the Diagnostics business, led by the base Molecular franchise.